PPG
GILD icon

Peak Planning Group’s Gilead Sciences GILD Stock Holding History

Peak Planning Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
1,710
+1
+0.1% +$132 0.05% 123
2026
Q1 		$238K Sell
1,709
-229
-12% -$32.1K 0.07% 109
2025
Q4 		$238K Buy
1,938
+31
+2% +$3.77K 0.07% 110
2025
Q3 		$212K Buy
1,907
+2
+0.1% +$227 0.11% 92
2025
Q2 		$211K Buy
1,905
+1
+0.1% +$106 0.14% 87
2025
Q1 		$213K Buy
+1,904
New +$196K 0.09% 112

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Peak Planning Group's GILD Position: Q2 2026 in Review

Peak Planning Group increased its Gilead Sciences (GILD) stake by 0.06% in Q2 2026, buying an estimated $132 and bringing the position to 1,710 shares worth $216K. The position accounts for 0.05% of the portfolio, ranked #123.

Peak Planning Group first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $238K in Q1 2026. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Peak Planning Group held 1,710 shares of Gilead Sciences worth $216K as of Q2 2026.
  • Peak Planning Group bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up 0.05% of Peak Planning Group's portfolio in Q2 2026, its #123 holding.
  • Peak Planning Group first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Peak Planning Group's Gilead Sciences position peaked at $238K in Q1 2026.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Peak Planning Group's 13F filing for Q2 2026, filed 12 Aug 2026.